REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Contains Seven Members Including Nitrogen, Carbon And Chalcogen > Plural Ring Nitrogens In The Seven-membered Hetero Ring Plural Ring Nitrogens In The Seven-membered Hetero RingPlural Ring Nitrogens In The Seven-membered Hetero Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/21/06 - 20060287294 - Aspartyl protease inhibitors Also disclosed is the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases. Also disclosed are methods of treating cognitive or neurodegenerative diseases using the compounds of formula I in combination with a cholinesterase inhibitor or a muscarinic m1 agonist or ... 09/07/06 - 20060199797 - Use of an ibat inhibitor for the treatment of prophylaxis of constipation The use of an IBAT inhibitor in the treatment and/or prophylaxis of constipation, in a warm-blooded animal, such as man is described. ... 08/03/06 - 20060172991 - Use of inhibitors of jun n-terminal kinases to treat glaucoma Compositions and methods for lowering IOP and/or providing neuroprotection are disclosed. The compositions and methods are particularly directed to the use inhibitors of Jun N-terminal kinases (JNK) to lower IOP and/or provide neuroprotection. ... 08/03/06 - 20060172990 - Antibacterial agents Compounds of formula (I) have antibacterial activity, wherein Q represents —N(OH)CH(═O) or —C(═)NH(OH); Y represents —C(═O)—, —C(═S)—, —S(═O)—, or —SO2—; R1 represents hydrogen, C1-C6 alkyl or C1-C6 alkyl substituted by one or more halogen atoms, or, except when Q is a radical of formula —N(OH)CH(═O), a hydroxy, C1-C6 alkoxy, C1-C6 ... 03/30/06 - 20060069082 - Novel substituted thiophenecarboxamides, their preparation and their use as medicaments in which A, Ar and R1 to R5 are as defined in Claim 1, their tautomers, their enantiomers, their diastereomers, their mixtures and their salts, especially their physiologically acceptable salts with inorganic or organic acids or bases, which have valuable properties. ... 09/15/05 - 20050203078 - New carboxylic acid amides, the preparation thereof and their use as medicaments wherein A, B and R1 to R5 are defined as in claim 1, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties. ... 07/21/05 - 20050159404 - Organic compound A combination which comprises (a) a staurosporine derivative and (b) an agent effective in preventing, delaying or treating transplant rejection in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one ... 07/21/05 - 20050159403 - Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage The present invention provides compositions and methods for the treatment of central nervous system damage in a subject. More particularly, the invention provides a combination therapy for the treatment of a vaso-occlusive event, such as a stroke, comprising the administration to a subject of a calcium modulating agent and a ... ### FreshPatents.com Support |